Encompass Health reports results for first quarter 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall St set to open lower as chip rout extends; Netflix slides
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Goldman sees central bank demand providing a floor for gold prices
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
Encompass Health Corporation (EHC) Tops Q1 EPS by 19c, Offers Guidance
April 24, 2024 4:19 PM EDTEncompass Health Corporation (NYSE: EHC) reported Q1 EPS of $1.12, $0.19 better than the analyst estimate of $0.93. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.27 billion.
GUIDANCE:
Encompass Health Corporation sees FY2024 EPS of $3.86-$4.11, versus the consensus... More
